Author Correction: CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity

Josephine B Walton; Malcolm Farquharson; Susan Mason; Jennifer Port; Bjorn Kruspig; Suzanne Dowson; David Stevenson; Daniel Murphy; Martin Matzuk; Jaeyeon Kim; Seth Coffelt; Karen Blyth; Iain A McNeish

doi:10.1038/s41598-018-24099-3

Author Correction: CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity

Sci Rep. 2018 Apr 13;8(1):6231. doi: 10.1038/s41598-018-24099-3.

Authors

Affiliations

¹ Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
² Cancer Research UK Beatson Institute, Glasgow, UK.
³ Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
⁴ Departments of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN, USA.
⁵ Institute of Cancer Sciences, University of Glasgow, Glasgow, UK. [email protected].

Abstract

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Publication types

Published Erratum